ArticleFrontiers in public health2025

Delayed access to innovative medicines in Romania: a comprehensive analysis of the reimbursement processes (2015-2024).

Constantin Radu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.